CLIMB BIO, INC. Accrued Liabilities and Other Liabilities
CLIMB BIO, INC. (CLYM) had Accrued Liabilities and Other Liabilities of $4.30 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2026-08-06
- 2026-06-30: Accrued Liabilities and Other Liabilities $4.30M.
- 2026-03-31: Accrued Liabilities and Other Liabilities $2.95M.
- 2025-12-31: Accrued Liabilities and Other Liabilities $4.46M.
- 2025-09-30: Accrued Liabilities and Other Liabilities $4.24M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2026-06-30 | $4.30M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.95M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $4.46M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $4.24M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $5.04M 10-Q · filed 2025-08-12 |
| 2024-12-31 | $4.07M 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |